Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Breast Neoplasms"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Study+Type%3A+Interventional%22&type=Subject&filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22
/vufind/Search/Results?lookfor=%22Study+Type%3A+Interventional%22&type=Subject&filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22
Search /vufind/Search2/Results?lookfor=%22Study+Type%3A+Interventional%22&type=Subject&filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22
PubPharm (8.068)
1
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer : MONARCH 2: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Fulvestrant With or Without Abemaciclib, a CDK4/6 Inhibitor, for Women With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy : A Phase 1B Clinical Trial to Evaluate the Safety and Immune Response to a Mammaglobin-A DNA Vaccine in ER+, HER2- Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy or Chemotherapy
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer : A Randomized, Open-Label, Phase 2 Study of Abemaciclib Plus Tamoxifen or Abemaciclib Alone, in Women With Previously Treated Hormone Receptor-Positive, HER2-Negative, Metastatic Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer : A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Compare NSAI (Anastrozole or Letrozole) Plus Abemaciclib, a CDK4 and CDK6 Inhibitor, or Plus Placebo, and to Compare Fulvestrant Plus Abemaciclib or Plus Placebo in Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Locoregionally Recurrent or Metastatic Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Tracking Triple-negative Breast Cancer Evolution Through Therapy : Tracking Triple-negative Breast Cancer Evolution Through Therapy
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Evaluation of the Efficacy and Safety of Nal-IRI for Progressing Brain Metastases in Breast Cancer Patients : Multicenter Open-label, Phase II Trial, to Evaluate the Efficacy and Safety of Nal-IRI for Progressing Brain Metastases in Patients With HER2-negative Breast Cancer (The Phenomenal Study)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy : Atorvastatin in Triple-Negative Breast Cancer (TNBC) Patients Who Did Not Achieve a Pathologic Complete Response (pCR) After Receiving Neoadjuvant Chemotherapy, a Multicenter Pilot Study
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer : Prophylactic Lymphovenous Bypass Procedure Following Axillary Lymphadenectomy in Patients With Inflammatory Breast Cancer: A Prospective, Randomized Study
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
AKT Inhibitor, Ipatasertib, With Endocrine and CDK 4/6 Inhibitor for Patients With Metastatic Breast Cancer (TAKTIC) : Clinical Trial to Evaluate Safety and Anti-tumor Activity of AKT Inhibitor, Ipatasertib,With Endocrine Therapy With/Without CDK 4/6 Inhibitor for Patients With Metastatic Hormone Receptor Positive Breast Cancer (TAKTIC)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer : Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Subjects With Unresectable Locally-advanced or Metastatic HER2+ Breast Cancer (HER2CLIMB-02)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[807]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Breast Neoplasms
Medienart
8.068
Aufsätze
8.068
E-Artikel
8.068
E-Ressourcen
Zeitschriftentitel
8.068
ClinicalTrials.gov
Thema
8.068
610
Breast Neoplasms
8.068
Study Type: Interventional
3.275
Recruitment Status: Completed
2.486
Phase: Phase 2
1.875
Medical Condition: Breast Cancer
1.784
Recruitment Status: Recruiting
951
Phase: Phase 3
950
Recruitment Status: Active, not recruiting
915
Phase: Phase 1
729
Recruitment Status: Terminated
694
Triple Negative Breast Neoplasms
488
Recruitment Status: Unknown status
478
Recruitment Status: Not yet recruiting
470
Carcinoma
333
Neoplasms
296
Phase: Phase 1, Phase 2
295
Medical Condition: Metastatic Breast Cancer
295
Recruitment Status: Withdrawn
222
Medical Condition: Breast Neoplasms
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
5.140
2020-
2.792
2010-2019
136
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
8.068
Englisch
Haven't found what you're looking for?
Wird geladen...